Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

RAG1/2 expression in follicular lymphoma marks candidate precursor cells of high-grade B cell lymphoma with MYC and BCL2 rearrangements

Stefano Casola, Silvia Lonardi, Piera Balzarini, Gaia Morello, Gabriele Varano, Vilma Pellegrini, Valeria Cancila, Sabrina Giampaolo, Emma Albertini, Heidi Thanasi, Daniele Lorenzini, Marco Pizzi, Fabio Facchetti, Maurilio Ponzoni, Luisa Lorenzi, Claudio Tripodo

Blood (2025) 146 (Supplement 1): 3534.

https://doi.org/10.1182/blood-2025-3534

Published: 2025

Journal Articles

Spatial multi-omics reveal distinct immunosuppressive lipid-laden macrophages in primary CNS lymphoma compared to systemic DLBCL

Blood (2025) 146 (Supplement 1): 146.

https://doi.org/10.1182/blood-2025-146

Published: 2025

Journal Articles

ATR inhibition with nucleoside analog therapy synergistically overcomes chemoresistance and reprograms dark zone lymphomas toward immune-accessible phenotypes

Allison SY Chan, Phuong Hoang, Akshaya Anbuselvan, Sharon Chan, Joseph J Zhao, Yuan Ju, Jane JH Lee, Tze King Tan, Wai Leong Tam, Takaomi Sanda, Edward Chow, Claudio Tripodo, Anand Devaprasath Jeyasekharan

Blood (2025) 146 (Supplement 1): 1536.

https://doi.org/10.1182/blood-2025-1536

Published: 2025

Journal Articles

Humanized PDX models reveal Lymphoma–Host interactions and enhanced T-cell therapies via epigenetic modulation

Blood (2025) 146 (Supplement 1): 350.

https://doi.org/10.1182/blood-2025-350

Published: 2025

Journal Articles

Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation

Blood (2025) 146 (Supplement 1): 5339.

https://doi.org/10.1182/blood-2025-5339

Published: 2025

Journal Articles

B Cell Receptor Inactivation Boosts NK Cell Killing of MYC-Driven Lymphomas

Gabriele Varano, Hiroshi Arima, Nicara C Parr, Eleonora Sala, Marta Mangione, Karlo Mladenic, Gaia Morello, Federica Mainoldi, Silvia Brambillasca, Adrian Andronache, Vanna Imsirovic, Ciro Mercurio, Felix Wensveen, Bojan Polic, Mirela Kuka, Claudio Tripodo, Stefano Casola

Blood (2024) 144 (Supplement 1): 334.

https://doi.org/10.1182/blood-2024-200555

Published: 2024

Journal Articles

B Cell Receptor Silencing Reveals Origin and Impacts Treatment of High-Grade B Cell Lymphomas with MYC and BCL2 Rearrangements

Blood (2024) 144 (Supplement 1): 453.

https://doi.org/10.1182/blood-2024-203258

Published: 2024

Journal Articles

Inhibition of Fibroblast Growth Factor-23 (FGF-23) Rescues Bone and Hematopoietic Stem Cell Niche Defects in Beta-Thalassemia, Uncovering the Missing Link between Hematopoiesis and Bone

Annamaria Aprile, Laura Raggi, Simona Bolamperti, Mariangela Storto, Isabella Villa, Gaia Morello, Sarah Marktel, Claudio Tripodo, Irene Motta, Maria Domenica Cappellini, Alessandro Rubinacci, Giuliana Ferrari

Blood (2021) 138 (Supplement 1): 572.

https://doi.org/10.1182/blood-2021-148366

Published: 2021

Journal Articles

Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche

Annamaria Aprile, Alessandro Gulino, Mariangela Storto, Isabella Villa, Stefano Beretta, Ivan Merelli, Alessandro Rubinacci, Maurilio Ponzoni, Sarah Marktel, Claudio Tripodo, Maria Rosa Lidonnici, Giuliana Ferrari

Blood (2020) 136 (5): 610–622.

https://doi.org/10.1182/blood.2019002721

Published: 2020

Includes: Supplemental data

Journal Articles

Hematopoietic Stem Cell Function in β-Thalassemia Is Impaired and Is Rescued By Targeting the Bone Marrow Niche

Annamaria Aprile, PhD, Alessandro Gulino, PhD, Isabella Villa, PhD, Stefano Beretta, PhD, Ivan Merelli, PhD, Alessandro Rubinacci, MD, Maurilio Ponzoni, MD, Sarah Marktel, MD, Claudio Tripodo, MD, Maria Rosa Lidonnici, PhD, Giuliana Ferrari, PhD

Blood (2019) 134 (Supplement_1): 967.

https://doi.org/10.1182/blood-2019-126829

Published: 2019

Journal Articles

Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Cirino Botta, MD, Giuseppe Gaipa, PhD, Maria Eugenia Gallo Cantafio, PhD, Chiara Buracchi, PhD, Maria Anna Siciliano, MD, Caterina Riillo, MD, Katia Grillone, PhD, Alessandro Gulino, Maria Cucè, Nicoletta Staropoli, Andrea Ghelli Luserna Di Rora, Franca Maria Tuccillo, Maria Teresa Di Martino, Claudio Tripodo, MD, Marco Rossi, MD, Giovanni Martinelli, Andrea Biondi, MD, Pierosandro Tagliaferri, Pierfrancesco Tassone, MD

Blood (2018) 132 (Supplement 1): 1418.

https://doi.org/10.1182/blood-2018-99-118572

Published: 2018

Journal Articles

Tumor Microenvironment (TME) Regulation of Programmed Death-1 (PD1) Receptor and Its Ligands PDL1 and PDL2 in Chronic Lymphocytic Leukemia (CLL)

Blood (2017) 130 (Supplement 1): 4291.

https://doi.org/10.1182/blood.V130.Suppl_1.4291.4291

Published: 2017

Journal Articles

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Blood (2017) 130 (Supplement 1): 4062.

https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062

Published: 2017

Journal Articles

Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma

Alessandra Romano, MD PhD, Nunziatina L Parrinello, Daniele Tibullo, PhD, Calogero Vetro, MD, Cesarina Giallongo, Piera La Cava, Annalisa Chiarenza, Loredana Villari, Claudio Tripodo, MD, Giovanna Motta, Laura Caruso, Andrea Gallamini, MD, Stefano A Pileri, Francesco Di Raimondo, MD

Blood (2016) 128 (22): 1770.

https://doi.org/10.1182/blood.V128.22.1770.1770

Published: 2016

Journal Articles

Alteration of HSC Functions in Thalassemia

Annamaria Aprile, Maria Rosa Lidonnici, PhD, Alessandro Gulino, Claudio Tripodo, MD, Giacomo Mandelli, PhD, Giuliana Ferrari, PhD

Blood (2015) 126 (23): 4752.

https://doi.org/10.1182/blood.V126.23.4752.4752

Published: 2015

Journal Articles

Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

Fortunato Morabito, MD, Giovanna Cutrona, PhD, Anna Grazia Recchia, PhD, Marina Fabbi, Silvano Ferrini, Massimo Gentile, MD, Ernesto Vigna, Monica Colombo, Carlotta Massucco, MS, Sabrina Bossio, Laura De Stefano, Ugo Consoli, MD, Iolanda D. Vincelli, Caterina Musolino, Stefano Molica, MD, Antonino Neri, MD, Claudio Tripodo, MD, Manlio Ferrarini, MD

Blood (2015) 126 (23): 616.

https://doi.org/10.1182/blood.V126.23.616.616

Published: 2015

Journal Articles

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

Roberta Zappasodi, Giusi Ruggiero, Carla Guarnotta, Monica Tortoreto, Cristina Tringali, Alessandra Cavanè, Antonello D. Cabras, Lorenzo Castagnoli, Bruno Venerando, Nadia Zaffaroni, Alessandro M. Gianni, Filippo De Braud, Claudio Tripodo, Serenella M. Pupa, Massimo Di Nicola

Blood (2015) 125 (11): 1768–1771.

https://doi.org/10.1182/blood-2014-07-590034

Published: 2015

Includes: Supplemental data

Journal Articles

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Blood (2014) 124 (11): 1715–1726.

https://doi.org/10.1182/blood-2014-02-558296

Published: 2014

Includes: Supplemental data

Journal Articles

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

Blood (2014) 123 (12): 1836–1849.

https://doi.org/10.1182/blood-2013-04-497271

Published: 2014

Includes: Supplemental data

Journal Articles

The Pro-Inflammatory IL23/IL23R/IL17 Axis Is Active in IL23R-Expressing Circulating CLL Cells in Patients with Poor Prognosis

Fortunato Morabito, MD, Giovanna Cutrona, PhD, Anna Grazia Recchia, PhD, Sonia Fabris, PhD, Serena Matis, PhD, Monica Colombo, PhD, Sabrina Bossio, Massimo Gentile, MD, Carlotta Massucco, PhD, Laura De Stefano, Stefano Molica, MD, Caterina Musolino, MD, Fiorella Ilariucci, Gianluca Festini, MD, Francesco Di Raimondo, MD, Pierfrancesco Tassone, MD, Antonino Neri, Claudio Tripodo, MD, Manlio Ferrarini, MD

Blood (2012) 120 (21): 3889.

https://doi.org/10.1182/blood.V120.21.3889.3889

Published: 2012

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

RAG1/2 expression in follicular lymphoma marks candidate precursor cells of high-grade B cell lymphoma with MYC and BCL2 rearrangements

Spatial multi-omics reveal distinct immunosuppressive lipid-laden macrophages in primary CNS lymphoma compared to systemic DLBCL

ATR inhibition with nucleoside analog therapy synergistically overcomes chemoresistance and reprograms dark zone lymphomas toward immune-accessible phenotypes

Humanized PDX models reveal Lymphoma–Host interactions and enhanced T-cell therapies via epigenetic modulation

Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation

B Cell Receptor Inactivation Boosts NK Cell Killing of MYC-Driven Lymphomas

B Cell Receptor Silencing Reveals Origin and Impacts Treatment of High-Grade B Cell Lymphomas with MYC and BCL2 Rearrangements

Inhibition of Fibroblast Growth Factor-23 (FGF-23) Rescues Bone and Hematopoietic Stem Cell Niche Defects in Beta-Thalassemia, Uncovering the Missing Link between Hematopoiesis and Bone

Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche

Hematopoietic Stem Cell Function in β-Thalassemia Is Impaired and Is Rescued By Targeting the Bone Marrow Niche

Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Tumor Microenvironment (TME) Regulation of Programmed Death-1 (PD1) Receptor and Its Ligands PDL1 and PDL2 in Chronic Lymphocytic Leukemia (CLL)

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma

Alteration of HSC Functions in Thalassemia

Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

The Pro-Inflammatory IL23/IL23R/IL17 Axis Is Active in IL23R-Expressing Circulating CLL Cells in Patients with Poor Prognosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only